Literature DB >> 28630439

Recurrent cyclin D2 mutations in myeloid neoplasms.

V Khanna1,2,3, C A Eide1,4,5, C E Tognon1,4,5, J E Maxson1,4,6, B Wilmot1,7, D Bottomly1,7, S McWeeney1,7, D K Edwards V1,4,6, B J Druker1,4,5, J W Tyner1,4,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28630439      PMCID： PMC5763909          DOI： 10.1038/leu.2017.195

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  20 in total

1.  Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.

Authors:  Y Takano; Y Kato; M Masuda; Y Ohshima; I Okayasu
Journal:  J Pathol       Date:  1999-10       Impact factor: 7.996

2.  Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias.

Authors:  E Clappier; W Cuccuini; J M Cayuela; D Vecchione; A Baruchel; H Dombret; F Sigaux; J Soulier
Journal:  Leukemia       Date:  2006-01       Impact factor: 11.528

3.  Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.

Authors:  A-K Eisfeld; J Kohlschmidt; S Schwind; D Nicolet; J S Blachly; S Orwick; C Shah; M Bainazar; K W Kroll; C J Walker; A J Carroll; B L Powell; R M Stone; J E Kolitz; M R Baer; A de la Chapelle; K Mrózek; J C Byrd; C D Bloomfield
Journal:  Leukemia       Date:  2016-11-15       Impact factor: 11.528

4.  Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.

Authors:  M W Deininger; S A Vieira; Y Parada; L Banerji; E W Lam; G Peters; F X Mahon; T Köhler; J M Goldman; J V Melo
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

5.  Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.

Authors:  J M Hernández; M C del Cañizo; A Cuneo; J L García; N C Gutiérrez; M González; G Castoldi; J F San Miguel
Journal:  Ann Oncol       Date:  2000-04       Impact factor: 32.976

6.  Deletion of the long arm of chromosome 20 in a patient with chronic neutrophilic leukemia: cytogenetic findings in chronic neutrophilic leukemia.

Authors:  S Matano; S Nakamura; K Kobayashi; T Yoshida; T Matsuda; T Sugimoto
Journal:  Am J Hematol       Date:  1997-01       Impact factor: 10.047

7.  Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.

Authors:  J R Alt; J L Cleveland; M Hannink; J A Diehl
Journal:  Genes Dev       Date:  2000-12-15       Impact factor: 11.361

8.  Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Authors:  Rocco Piazza; Simona Valletta; Nils Winkelmann; Sara Redaelli; Roberta Spinelli; Alessandra Pirola; Laura Antolini; Luca Mologni; Carla Donadoni; Elli Papaemmanuil; Susanne Schnittger; Dong-Wook Kim; Jacqueline Boultwood; Fabio Rossi; Giuseppe Gaipa; Greta P De Martini; Paola Francia di Celle; Hyun Gyung Jang; Valeria Fantin; Graham R Bignell; Vera Magistroni; Torsten Haferlach; Enrico Maria Pogliani; Peter J Campbell; Andrew J Chase; William J Tapper; Nicholas C P Cross; Carlo Gambacorti-Passerini
Journal:  Nat Genet       Date:  2012-12-09       Impact factor: 38.330

9.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528

10.  Overexpression of cyclin D2 in chronic B-cell malignancies.

Authors:  A Delmer; F Ajchenbaum-Cymbalista; R Tang; S Ramond; A M Faussat; J P Marie; R Zittoun
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113
View more
  6 in total

1.  The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p.

Authors:  Mu Xu; Xiaoxiang Chen; Kang Lin; Kaixuan Zeng; Xiangxiang Liu; Bei Pan; Xueni Xu; Tao Xu; Xiuxiu Hu; Li Sun; Bangshun He; Yuqin Pan; Huiling Sun; Shukui Wang
Journal:  Mol Cancer       Date:  2018-09-28       Impact factor: 27.401

Review 2.  Structural insights into the functional diversity of the CDK-cyclin family.

Authors:  Daniel J Wood; Jane A Endicott
Journal:  Open Biol       Date:  2018-09       Impact factor: 6.411

Review 3.  t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming.

Authors:  Sophie Kellaway; Paulynn S Chin; Farnaz Barneh; Constanze Bonifer; Olaf Heidenreich
Journal:  Cells       Date:  2020-12-13       Impact factor: 6.600

4.  The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

Authors:  Natalia Martinez-Soria; Lynsey McKenzie; Julia Draper; Anetta Ptasinska; Hasan Issa; Sandeep Potluri; Helen J Blair; Anna Pickin; Asmida Isa; Paulynn Suyin Chin; Ricky Tirtakusuma; Daniel Coleman; Sirintra Nakjang; Salam Assi; Victoria Forster; Mojgan Reza; Ed Law; Philip Berry; Dorothee Mueller; Cameron Osborne; Alex Elder; Simon N Bomken; Deepali Pal; James M Allan; Gareth J Veal; Peter N Cockerill; Christian Wichmann; Josef Vormoor; Georges Lacaud; Constanze Bonifer; Olaf Heidenreich
Journal:  Cancer Cell       Date:  2018-10-08       Impact factor: 38.585

Review 5.  The RUNX1/RUNX1T1 network: translating insights into therapeutic options.

Authors:  Laura E Swart; Olaf Heidenreich
Journal:  Exp Hematol       Date:  2020-11-17       Impact factor: 3.084

6.  CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients.

Authors:  Bruno Cassinat; Emmanuelle Verger; Nabih Maslah; Nicolas Gauthier; William Vainchenker; Stéphane Giraudier; Jean-Jacques Kiladjian
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.